Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems Recombinant Protein;Biotinylated Human Siglec-2 / CD22 Protein, Fc Tag, Avi Tag (Avitag™);HEK293;25UG;SI2,CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,Siglec-2,SIGLEC2FLJ22814,T-cell surface antigen Leu-14

Manufacturer:  ACROBiosystems SI2H82F825UG


Recombinant Protein;Biotinylated Human Siglec-2 / CD22 Protein, Fc Tag, Avi Tag (Avitag™);25UG;Biotinylated Human Siglec-2, Fc Tag, Avi Tag (SI2-H82F8) is expressed from human 293 cells (HEK293). It contains AA Asp 20 - Arg 687 (Accession # P20273-1).;This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag (Avitag™). The protein has a calculated MW of 103.9 kDa. The protein migrates as 115-120 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Immobilized Anti-Human CD22 MAb at 0.5 μg/mL (100 μL/well) can bind Biotinylated Human Siglec-2, Fc Tag, Avi Tag (Cat. No. SI2-H82F8) with a linear range of 1-16 ng/mL (QC tested).;293 cells were transfected with anti-CD22-scFv and RFP tag. 2e5 of the cells were first stained with B. Biotinylated Human Siglec-2 / CD22 Protein, Fc Tag, Avi Tag (Cat. No. SI2-H82F8, 10 μg/ml) and C. Biotinylated Protein Control, followed by FITC Streptavidin. A. Non-transfected 293 cells and C. Biotinylated Pro

Catalog No. 50-165-7927

Add to cart

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit